anti-SARS-CoV-2 Nucleocapsid Chimeric Human, Rabbit Monoclonal (RMH03)
REV-54-1306-00
Overview
- SupplierRevMAb Biosciences
- Product Nameanti-SARS-CoV-2 Nucleocapsid Chimeric Human, Rabbit Monoclonal (RMH03)
- Delivery Days Customer5
- Antibody SpecificityThis antibody reacts to 2019-nCov Nucleocapsid Protein.
- ApplicationsELISA
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDRMH03
- Concentration1 mg/ml
- FormulationLiquid
- Gene ID1489678
- Target nameN
- Target descriptionORF9a protein;nucleocapsid protein
- Target synonymsORF9a protein;nucleocapsid protein; sars9a
- HostHuman
- IsotypeIgG
- Protein IDP59595
- Protein NameNucleoprotein
- Scientific Description25-Hydroxyvitamin D3 is produced in the liver by 25-hydroxylation of cholecalciferol or Vitamin D3. It is a precursor for other Vitamin D3 metabolites and has only a limited biological activity in itself. Detection of 25-Hydroxyvitamin D3 is important for the diagnosis of Vitamin D deficiency, insufficiency or intoxication. - Recombinant Antibody. This antibody reacts to 2019-nCov Nucleocapsid Protein. Applications: ELISA. Clone: RMH03. Isotype: Rabbit/Human ChimericRabbit Fv/ Human IgG CH and Ckappa. Formulation: Liquid in PBS. 25-Hydroxyvitamin D3 is produced in the liver by 25-hydroxylation of cholecalciferol or Vitamin D3. It is a precursor for other Vitamin D3 metabolites and has only a limited biological activity in itself. Detection of 25-Hydroxyvitamin D3 is important for the diagnosis of Vitamin D deficiency, insufficiency or intoxication.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203